ERNA - Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.